Authors
Lanclus M, Clukers J, Van Holsbeke C, Vos W, Leemans G, Holbrechts B, Barboza K, De Backer W, De Backer J.
We are happy to announce that a few days ago the positive results of AstraZeneca’s Bevespi (LABA/LAMA), compared to placebo have been published in the International Journal of COPD. The study shows how FRI confirmed the strong, homogeneous effect of the innovative co-suspension bronchodilator compared to placebo, as seen in earlier studies. At the same… Continue Reading
Int J Chron Obstruct Pulmon Dis. 2018 Aug 30;13:2673-2684. Authors De Backer W, De Backer J, Vos W, Verlinden I, Van Holsbeke C, Clukers J, Hajian B, Siddiqui S, Jenkins M, Reisner C, Martin UJ. Read more Continue Reading
Int J Chron Obstruct Pulmon Dis. 2018; 13: 1783–1792. Authors van Geffen WH, Hajian B, Vos W, De Backer J, Cahn A, Usmani OS, Van Holsbeke C, Pistolesi M, Kerstjens HAM, De Backer W Read more Continue Reading
Int J Chron Obstruct Pulmon Dis. 2018 Mar 6;13:833-842. Authors Bita Hajian, Jan De Backer, Wim Vos, Wouter H van Geffen, Paul De Winter, mar Usmani, Tony Cahn, Huib AM Kerstjens, Massimo Pistolesi, Wilfried De Backer Read more Continue Reading
Not only will FLUIDDA present at the first Respiratory Innovation Summit at the American Thoracic Society conference 2018, we also have a strong scientific program with 7 Functional Respiratory Imaging related presentations. Looking forward to seeing you at booth 2542! Sunday, May 20 Monday, May 21 Tuesday, May… Continue Reading
Int J Chron Obstruct Pulmon Dis. 2017 Jul 28;12:2197-2205 Authors Hajian B, De Backer J, Sneyers C, Ferreira F, Barboza KC, Leemans G, Vos W, De Backer W. Read more Continue Reading
We are proud to announce that we’ve signed a Memorandum of Understanding with Ciro to join forces to improve patient-care of COPD patients in the Netherlands. We both share the same vision around personalised medicine: customised to the patient with a Value Based Healthcare approach. Value-based healthcare is a healthcare delivery model in which providers,… Continue Reading
For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register for the Webcast via following link: https://attendee.gotowebinar.com/register/8186175617140384514 FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device… Continue Reading
“Functional Respiratory Imaging (FRI) provided valuable insights throughout the development process of iNO in COPD patients with PH. The therapy was effective in the initial studies and has great potential to improve the lives of these severely affected patients” Dr. J. De Backer, CEO FLUIDDA Changes in Blood Vessel Volume determined using Functional Respiratory… Continue Reading
Fluidda NV
Groeningenlei 132
2550 Kontich
Belgium
BE 0877 160 706
Tel: +32/(0)3 450 87 20
Fax: +32/(0)3 450 87 29
info@fluidda.com
Fluidda NV
Groeningenlei 132
2550 Kontich
Belgium
BE 0877 160 706
Tel: +32/(0)3 450 87 20
Fax: +32/(0)3 450 87 29
info@fluidda.com
FLUIDDA, Inc
675 US Highway One
North Brunswick, NJ 08902
United States
FLUIDDA, Inc
675 US Highway One
North Brunswick, NJ 08902
United States
FLUIDDA India
Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India
FLUIDDA India
Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India
All content © FLUIDDA 2019
